Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dapiglutide

A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide

Zealand Pharma · Phase 1 · Completed · Enrollment 30

NCT06758583

EudraCT 2024-516901-21

ArmPopulationDoseWeeksEstimandWeight change
Dapiglutide 10 mg/mLObesity or overweight10 mgn/rn/rn/r
Dapiglutide 25 mg/mLObesity or overweight25 mgn/rn/rn/r